Alternative Indexes to Estimate the Functional Capacity From the 6-Minute Walk Test in Children and Adolescents With Cystic Fibrosis

References

1. 1.↵
   1. Mogayzel PJ Jr.,
   2. Flume PA

   . Update in Cystic Fibrosis 2009. Am J Respir Crit Care Med 2010;181(6):539–544.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Kuca K,
   2. Klimova B,
   3. Novotny M,
   4. Maresova P

   . Cystic fibrosis revisited: a review study. Med Chem 2016. [Epub ahead of print].
3. 3.↵
   1. Narang I,
   2. Pike S,
   3. Rosenthal M,
   4. Balfour-Lynn IM,
   5. Bush A

   . Three-minute step test to assess exercise capacity in children with cystic fibrosis with mild lung disease. Pediatr Pulmonol 2003;35(2):108–113.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Cox NS,
   2. Alison JA,
   3. Button BM,
   4. Wilson JW,
   5. Morton JM,
   6. Holland AE

   . Physical activity participation by adults with cystic fibrosis: an observational study. Respirology 2016;21(3):511–518.

   OpenUrl
5. 5.↵
   1. Gruet M,
   2. Brisswalter J,
   3. Mely L,
   4. Vallier JM

   . Use of the peak heart rate reached during six-minute walk test to predict individualized training intensity in patients with cystic fibrosis: validity and reliability. Arch Phys Med Rehabil 2010;91(4):602–607.

   OpenUrlPubMed
6. 6.↵
   1. Noonan V,
   2. Dean E

   . Submaximal exercise testing: clinical application and interpretation. Phys Ther 2000;80(8):782–807.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Arikan H,
   2. Yatar İ,
   3. Calik-Kutukcu E,
   4. Aribas Z,
   5. Saglam M,
   6. Vardar-Yagil N,
   7. et al

   . A comparison of respiratory and peripheral muscle strength, functional exercise capacity, activities of daily living and physical fitness in patients with cystic fibrosis and healthy subjects. Res Dev Disabil 2015;45(46):147–156.

   OpenUrl
8. 8.↵
   ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–117.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Gulmans VA,
   2. van Veldhoven NH,
   3. de Meer K,
   4. Helders PJ

   . The six-minute walking test in children with cystic fibrosis: reliability and validity. Pediatr Pulmonol 1996;22(2):85–89.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Carter R,
    2. Holiday DB,
    3. Nwasuruba C,
    4. Stocks J,
    5. Grothues C,
    6. Tiep B

    . 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003;123(5):1408–1415.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Chuang ML,
    2. Lin IF,
    3. Wasserman K

    . The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO₂ in COPD patients. Respir Med 2001;95(7):618–626.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Graham JE,
    2. Ostir GV,
    3. Kuo YF,
    4. Fisher SR,
    5. Ottenbacher KJ

    . Relationship between test methodology and mean velocity in timed walk tests: a review. Arch Phys Med Rehabil 2008;89(5):865–872.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Bratteby Tollerz LU,
    2. Olsson RM,
    3. Forslund AH,
    4. Norrlin SE

    . Reliability of energy cost calculations in children with cerebral palsy, cystic fibrosis and health controls. Acta Paediatr 2011;100(12):1616–1620.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Butler P,
    2. Engelbrecht M,
    3. Major RE,
    4. Tait JH,
    5. Stallard J,
    6. Patrick JH

    . Physiological cost index of walking for normal children and its use as an indicator of physical handicap. Dev Med Child Neurol 1984;26(5):607–612.

    OpenUrlPubMedWeb of Science
15. 15.↵
    1. Stott FD,
    2. Raftery EB,
    3. Goulding L

    1. MacGregor J

    . The objective measurement of physical performance with long-term ambulatory physiological surveillance equipment. In: Stott FD, Raftery EB, Goulding L, editors. Proceedings of the Third International Symposium on Ambulatory Monitoring. London: Academic Press; 1979:29–39.
16. 16.↵
    1. Kanga J,
    2. Kuhn R,
    3. Craigmyle L,
    4. Haverstock D,
    5. Church D

    . Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther 1999;21(8):1343–1356.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Hafen GM,
    2. Ranganathan SC,
    3. Robertson CF,
    4. Robinson PJ

    . Clinical scoring system in cystic fibrosis. Pediatr Pulmonol 2006;41(7):602–617.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Shwachman H,
    2. Kulczycki LL

    . Long term study of one hundred five patients with cystic fibrosis. Am J Dis Child 1958;96(18):6–15.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Doeurshuk CF,
    2. Matthews LW,
    3. Tucker AS,
    4. Nudelman H,
    5. Eddy G,
    6. Wise M,
    7. Spector S

    . A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosis. J Pediatr 1964;65(5):677–693.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Santos CIS,
    2. Ribeiro JD,
    3. Ribeiro AF,
    4. Hessel G

    . Critical analysis of scoring systems used in the assessment of cystic fibrosis severity: state of the art. J Bras Pneumol 2004;30(3):286–298.

    OpenUrl
21. 21.↵
    1. Priesnitz CV,
    2. Rodrigues GH,
    3. Stumpf Cda S,
    4. Viapiana G,
    5. Cabral CP,
    6. Stein RT,
    7. et al

    . Reference values for the 6-min walk test in healthy children aged 6-12 years. Pediatr Pulmonol 2009;44(12):1174–1179.

    OpenUrlCrossRefPubMed
22. 22.↵
    Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para testes de função pulmonar. J Pneumol 2002;28(3):S1–S238.

    OpenUrl
23. 23.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . ATS/ERS statement: standardisation of lung function testing. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Rasekaba T,
    2. Lee AL,
    3. Naughton MT,
    4. Williams TJ,
    5. Holland AE

    . The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009;39(8):495–501.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Lands LC,
    2. Heigenhauser GJ,
    3. Jones NL

    . Analysis of factors limiting maximal exercise performance in cystic fibrosis. Clin Sci 1992;83(4):391–397.

    OpenUrlPubMed
26. 26.↵
    1. Coates AL,
    2. Boyce P,
    3. Muller D,
    4. Mearns M,
    5. Godfrey S

    . The role of nutritional status, airway obstruction, hypoxia, and abnormalities in serum lipid composition in limiting exercise tolerance in children with cystic fibrosis. Acta Paediatr Scand 1980;69(3):353–358.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Prasad SA,
    2. Cerny FJ

    . Factors that influence adherence to exercise and their effectiveness: application to cystic fibrosis. Pediatr Pulmonol 2002;34(1):66–72.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Wilkes DL,
    2. Schneiderman JE,
    3. Nguyen T,
    4. Heale L,
    5. Moola F,
    6. Ratjen F,
    7. et al

    . Exercise and physical activity in children with cystic fibrosis. Paediatr Respir Rev 2009;10(3):105–109.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Nixon PA,
    2. Joswiak ML,
    3. Fricker FJ

    . A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr 1996;129(3):362–366.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Boucher GP,
    2. Lands LC,
    3. Hay JA,
    4. Hornby L

    . Activity levels and the relationship to lung function and nutritional status in children with cystic fibrosis. Am J Phys Med Rehabil 1997;76(4):311–315.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Rogers D,
    2. Prasad SA,
    3. Doull J

    . Exercise testing in children with cystic fibrosis. J R Soc Med 2003;96(43):23–29.

    OpenUrlFREE Full Text
32. 32.↵
    1. Morales-Blanhir JE,
    2. Palafox Vidal CD,
    3. Rosas Romero Mde J,
    4. García Castro MM,
    5. Londoño Villegas A,
    6. Zamboni M

    . Six-minute walk test: a valuable tool for assessing pulmonary impairment. J Bras Pneumol 2011;37(1):110–117.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Cahalin L,
    2. Pappagianopoulos P,
    3. Prevost S,
    4. Wain J,
    5. Ginns L

    . The relationship of the 6-min walk test to maximal oxygen consumption in transplant patients with end-stage lung disease. Chest 1995;108(2):452–459.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Puhan MA,
    2. Mador MJ,
    3. Held U,
    4. Goldstein R,
    5. Guyatt GH,
    6. Schümann HJ

    . Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008;32(3):637–643.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Holland AE,
    2. Hill CJ,
    3. Rasekaba T,
    4. Lee A,
    5. Naughton MT,
    6. McDonald CF

    . Updating the minimal importance difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010;91(2):221–225.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Geiger R,
    2. Strasak A,
    3. Treml B,
    4. Gasser K,
    5. Kleinsasser A,
    6. Fischer V,
    7. et al

    . Six-minute walk test in children and adolescents. J Pediatr 2007;150(4):395–399.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.
    1. Lammers AE,
    2. Hislop AA,
    3. Flynn Y,
    4. Haworth SG

    . The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child 2008;93(6):464–468.

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Li AM,
    2. Yin J,
    3. Au JT,
    4. So HK,
    5. Tsang T,
    6. Wong E,
    7. et al

    . Standard reference for the 6-minute walk test in healthy children aged 7 to 16 years. Am J Respir Crit Care Med 2007;176(2):174–180.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Hill K,
    2. Jenkins SC,
    3. Cecins N,
    4. Philippe DL,
    5. Hillman DR,
    6. Eastwood PR

    . Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2008;89(9):1782–1787.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Karpman C,
    2. DePew ZS,
    3. LeBrasseur NK,
    4. Novotny PJ,
    5. Benzo RP

    . Determinants of gait speed in COPD. Chest 2014;146(1):104–110.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.↵
    1. Orenstein DM,
    2. Franklin BA,
    3. Doershuk CF,
    4. Hellerstein HK,
    5. Germann KJ,
    6. Horowitz JG,
    7. Stern RC

    . Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three months supervised running program. Chest 1981;80(4):392–398.

    OpenUrlCrossRefPubMedWeb of Science
42. 42.↵
    1. Selvadurai HC,
    2. McKay KO,
    3. Blimkie CJ,
    4. Cooper PJ,
    5. Mellis CM,
    6. Van Asperen PP

    . The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 2002;165(6):762–765.

    OpenUrlCrossRefPubMedWeb of Science
43. 43.↵
    1. Almajed A,
    2. Lands LC

    . The evolution of exercise capacity and its limiting factors in cystic fibrosis. Paediatr Respir Rev 2012;13(4):195–199.

    OpenUrlCrossRefPubMed
44. 44.↵
    1. Pastré J,
    2. Prévotat A,
    3. Tardif C,
    4. Langlois C,
    5. Duhamel A,
    6. Wallaert B

    . Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease. BMC Pulm Med 2014;14:74.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Hommerding PX,
    2. Baptista RR,
    3. Makarewicz GT,
    4. Schindel CS,
    5. Donadio MV,
    6. Pinto LA,
    7. Marostica PJ

    . Effects of an educational intervention of physical activity for children and adolescents with cystic fibrosis: a randomized controlled trial. Respir Care 2015;60(1):81–87.

    OpenUrlAbstract/FREE Full Text
46. 46.↵
    1. Hebestreit H,
    2. Arets HG,
    3. Aurora P,
    4. Boas S,
    5. Cerny F,
    6. Hulzebos EH,
    7. et al

    . Statement on exercise testing in cystic fibrosis. Respiration 2015;90(4):332–351.

    OpenUrl